Cutaneous manifestations of chimeric antigen receptor T cell therapy: an introduction for dermatologists

Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm

Am J Dermatopathol.

Behdad A, Allen P, Lu X, Zhou XA, Guitart J, Chen Q, Pro B

doi: 10.1097/DAD.

Melanoma and Skin Cancer

Primary cutaneous acral CD8+ T-cell lymphoma of the ear: A case report

J Cutan Pathol.

Ormerod E, Murigu T, Pawade J, Beasley M, Dunnill G

doi: 10.1111/cup.13517.

Immunodeficiency

A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease

J Clin Immunol.

Shields AM, Bauman BM, Hargreaves CE, Pollard AJ, Snow AL, Patel SY

doi: 10.1007/s10875-019-00729-x.

Melanoma and Skin Cancer

[Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab]

Ann Dermatol Venereol.

Delaitre L, Martins-Héricher J, Truchot E, Denis D, Prophette B, Maillard H, Bénéton-Benhard N

doi: 10.1016/j.annder.2019.10.031.

Immunodeficiency

Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment

Front Immunol.

Zangari P, Cifaldi C, Di Cesare S, Di Matteo G, Chiriaco M, Amodio D, Cotugno N, De Luca M, Surace C, Ladogana S, Gardini S, Merli P, Algeri M, Rossi P, Palma P, Cancrini C, Finocchi A

doi: 10.3389/fimmu.2019.02471.

T Cells

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase

Front Immunol.

Howe MK, Dowdell K, Roy A, Niemela JE, Wilson W, McElwee JJ, Hughes JD, Cohen JI

doi: 10.3389/fimmu.2019.02000.

Melanoma and Skin Cancer

Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas

JAMA Dermatol.

Nichols AJ, Gonzalez A, Clark ES, Khan WN, Rosen AC, Guzman W, Rabinovitz H, Badiavas EV, Kirsner RS, Ioannides T

doi: 10.1001/jamadermatol.

Melanoma and Skin Cancer

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Br J Dermatol.

Gault A, Anderson AE, Plummer R, Stewart C, Pratt AG, Rajan N

doi: 10.1111/bjd.19750.Visit the original publication at ncbi.nlm.nih.gov

Immunodeficiency

Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report

Clin Case Rep.

Horowitz R, Freeman PR

doi: 10.1002/ccr3.1556.

Related content

Cutaneous T-Cell Lymphoma, a Novel Manifestation of PDGFRA-Rearranged Neoplasm

Primary cutaneous acral CD8+ T-cell lymphoma of the ear: A case report

A Novel, Heterozygous Three Base-Pair Deletion in CARD11 Results in B Cell Expansion with NF-κB and T Cell Anergy Disease

[Regression of cutaneous basal cell and squamous cell carcinoma under pembrolizumab]

Novel Compound Heterozygous Mutations in IL-7 Receptor α Gene in a 15-Month-Old Girl Presenting With Thrombocytopenia, Normal T Cell Count and Maternal Engraftment

Magnesium Restores Activity to Peripheral Blood Cells in a Patient With Functionally Impaired Interleukin-2-Inducible T Cell Kinase

Combined Systemic and Intratumoral Administration of Human Papillomavirus Vaccine to Treat Multiple Cutaneous Basaloid Squamous Cell Carcinomas

Cutaneous immune-related adverse events in patients with melanoma treated with checkpoint inhibitors

Improvement of common variable immunodeficiency using embryonic stem cell therapy in a patient with lyme disease: a clinical case report